tepmetko
Generic: tepotinib hydrochloride
Labeler: emd serono, inc.Drug Facts
Product Profile
Brand Name
tepmetko
Generic Name
tepotinib hydrochloride
Labeler
emd serono, inc.
Dosage Form
TABLET
Routes
Active Ingredients
tepotinib hydrochloride 225 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
44087-5000
Product ID
44087-5000_d922de79-b0f0-4ed2-b551-c7a86ed72d7d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA214096
Listing Expiration
2026-12-31
Marketing Start
2021-02-03
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
440875000
Hyphenated Format
44087-5000
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tepmetko (source: ndc)
Generic Name
tepotinib hydrochloride (source: ndc)
Application Number
NDA214096 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 225 mg/1
Packaging
- 3 BLISTER PACK in 1 CARTON (44087-5000-3) / 10 TABLET in 1 BLISTER PACK
- 6 BLISTER PACK in 1 CARTON (44087-5000-6) / 10 TABLET in 1 BLISTER PACK
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d922de79-b0f0-4ed2-b551-c7a86ed72d7d", "openfda": {"unii": ["VY5YX2TQ1F"], "rxcui": ["2477266", "2477272"], "spl_set_id": ["80a0f1b9-071a-47f5-9e67-32d638a669dc"], "manufacturer_name": ["EMD Serono, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (44087-5000-3) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "44087-5000-3", "marketing_start_date": "20210203"}, {"sample": false, "description": "6 BLISTER PACK in 1 CARTON (44087-5000-6) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "44087-5000-6", "marketing_start_date": "20210203"}], "brand_name": "TEPMETKO", "product_id": "44087-5000_d922de79-b0f0-4ed2-b551-c7a86ed72d7d", "dosage_form": "TABLET", "pharm_class": ["Kinase Inhibitor [EPC]", "Mesenchymal Epithelial Transition Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "44087-5000", "generic_name": "Tepotinib Hydrochloride", "labeler_name": "EMD Serono, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TEPMETKO", "active_ingredients": [{"name": "TEPOTINIB HYDROCHLORIDE", "strength": "225 mg/1"}], "application_number": "NDA214096", "marketing_category": "NDA", "marketing_start_date": "20210203", "listing_expiration_date": "20261231"}